Found: 1257
Select item for more details and to access through your institution.
863. Liver Gene Therapy for Hemophilia with phiC31 Integrase.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S332, doi. 10.1016/j.ymthe.2006.08.949
- By:
- Publication type:
- Article
860. Sustained Long-Term In Vivo Expression of Human Factor IX from Keratinocytes Transduced with HIV-Based Vectors.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S331, doi. 10.1016/j.ymthe.2006.08.946
- By:
- Publication type:
- Article
861. Recombinant Adeno-Associated Virus Vector Mediated Gene Therapy of Adenosine Deaminase Deficiency in a Mouse Model.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S331, doi. 10.1016/j.ymthe.2006.08.947
- By:
- Publication type:
- Article
862. Feasibility of Cutaneous Gene Therapy Using a Factor VIII Gene and a Marker Gene in Factor VIII-Deficient Mice by Non-Invasive Electroporation.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S332, doi. 10.1016/j.ymthe.2006.08.948
- By:
- Publication type:
- Article
859. Cats Produce a CTL Response That Reduces Expression of Human Factor IX and Human Factor VIII after Neonatal Gene Transfer and Represent an Important Model for Translation into Humans.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S331, doi. 10.1016/j.ymthe.2006.08.945
- By:
- Publication type:
- Article
864. Characterization of Transgenic Mice Over-Expressing Arylsulfatase A: Implications for Gene Therapy and Sulfatases Activation Mechanisms.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S332, doi. 10.1016/j.ymthe.2006.08.950
- By:
- Publication type:
- Article
865. In Vivo Gene Transfer of Prostacyclin Synthase by Using AAV Vector Prevents Monocrotaline-Induced Pulmonary Hypertension and Pulmonary Vasoconstriction in Rats.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S333, doi. 10.1016/j.ymthe.2006.08.953
- By:
- Publication type:
- Article
866. Aortic Disease in Mucopolysaccharidodis I Mice Is Due to Increased Expression of Matrix Metalloproteinase 12 (MMP 12) Can Be Prevented with Neonatal Retroviral Vector-Mediated Gene Therapy.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S333, doi. 10.1016/j.ymthe.2006.08.954
- By:
- Publication type:
- Article
867. Spliceosome Mediated RNA Trans-Splicing To Increase Blood Levels of Apolipoprotein A-I and High Density Lipoproteins<sup>*</sup>.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S334, doi. 10.1016/j.ymthe.2006.08.955
- By:
- Publication type:
- Article
868. Novel Strategies To Inhibit Ocular Neovascularization Based on Sonic Hedgehog Pathway Blockade.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S334, doi. 10.1016/j.ymthe.2006.08.956
- By:
- Publication type:
- Article
869. Accelerated Re-Endothelilization in eNOS Transduced Iliac Artery Following Gene Delivery from an Adenoviral Eluting Stent.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S334, doi. 10.1016/j.ymthe.2006.08.957
- By:
- Publication type:
- Article
870. NOS Isoforms, Intimal Hyperplasia and Endothelial Regeneration after Balloon Injury.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S335, doi. 10.1016/j.ymthe.2006.08.958
- By:
- Publication type:
- Article
871. Surface Modification of Adenovectors with TAT- and Antp-Containing Polymers Protects Them from Neutralizing Antibodies and Increases Expression of Reporter Genes In Vitro and In Vivo.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S335, doi. 10.1016/j.ymthe.2006.08.959
- By:
- Publication type:
- Article
872. Highly Efficient Virus-Mediated Gene Transfer to Human Vein Grafts Via Intraluminal Pressure Delivery.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S335, doi. 10.1016/j.ymthe.2006.08.960
- By:
- Publication type:
- Article
873. Development of High Throughput Functional Screening of Cardiovascular Therapeutic Genes Using the HVJ-E Vector.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S336, doi. 10.1016/j.ymthe.2006.08.961
- By:
- Publication type:
- Article
874. Prolonged Adenovirus and Adeno-Associated Virus-Mediated Gene Delivery to Rabbit Iliac Arteries Using Gene-Eluting Stents: A Direct Comparison.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S336, doi. 10.1016/j.ymthe.2006.08.962
- By:
- Publication type:
- Article
875. Development of Human Skin Gene Therapy for Systemic In Vivo Delivery of Atrial Natriuretic Peptide (ANP) To Treat Hypertension.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S337, doi. 10.1016/j.ymthe.2006.08.963
- By:
- Publication type:
- Article
876. Development of Novel Angiogenic DNA Medicine Using a Genomic/cDNA Hybrid of Hepatocyte Growth Factor Gene.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S337, doi. 10.1016/j.ymthe.2006.08.964
- By:
- Publication type:
- Article
877. Differential Expression of Indoleamine 2,3-dioxygenase (IDO) by Endothelial Cells and Its Overexpression by Gene Transfer: Implications for Cardiovascular Biology.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S337, doi. 10.1016/j.ymthe.2006.08.965
- By:
- Publication type:
- Article
878. Overexpression of Fibromodulin Inhibits Neointima Formation in Cultured Human Saphenous Veins.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S338, doi. 10.1016/j.ymthe.2006.08.966
- By:
- Publication type:
- Article
879. Effects of Continuous Expression of Activated Protein C (APC) in Novel Murine Thrombosis Models.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S338, doi. 10.1016/j.ymthe.2006.08.967
- By:
- Publication type:
- Article
880. Towards a Gene Therapy Treatment for Peripheral Vascular Disease – High Level of Expression of Angiogenic Genes in Rat Limb Muscle Following Intravenous Delivery of Plasmid DNAs.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S339, doi. 10.1016/j.ymthe.2006.08.968
- By:
- Publication type:
- Article
881. Safety, Efficacy and Biodistribution of Recombinant AAV2-RPE65 Vector Delivered by Ocular Subretinal Injection.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S339, doi. 10.1016/j.ymthe.2006.08.970
- By:
- Publication type:
- Article
882. Non-Viral Ocular Gene Transfer for Hereditary Retinal Degeneration.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S340, doi. 10.1016/j.ymthe.2006.08.971
- By:
- Publication type:
- Article
883. AAV-2 Based Gene Therapy Using Novel Anti-VEGF Molecules for Inhibition of Angiogenesis in the Eye.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S340, doi. 10.1016/j.ymthe.2006.08.972
- By:
- Publication type:
- Article
884. Anti-Oxidant Gene Delivery to Retinal Epithelial Cells: A Gene Therapy Approach for Macular Degeneration.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S340, doi. 10.1016/j.ymthe.2006.08.973
- By:
- Publication type:
- Article
885. AAV-Mediated Gene Transfer of Constitutively and Pharmacologically-Activated Glial Cell-Derived Neurotrophic Factor Receptor To Inhibit Retinal Degeneration.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S341, doi. 10.1016/j.ymthe.2006.08.974
- By:
- Publication type:
- Article
886. AAV-Mediated Somatic Gene Transfer as an Approach To Delineate Pathogenic Mechanisms in an Autosomal Dominant Blindness Disorder Resembling Age-Related Macular Degeneration (AMD).
- Published in:
- Molecular Therapy, 2006, v. 13, p. S341, doi. 10.1016/j.ymthe.2006.08.975
- By:
- Publication type:
- Article
887. G Protein-Coupled Receptor Kinase Interacting Protein 1 Slows down the Apoptosis Process of Retinal Ganglion Cells in a Rat Model.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S341, doi. 10.1016/j.ymthe.2006.08.976
- By:
- Publication type:
- Article
888. Characterization of New Murine Models of Globoid Cell Leukodystrophy: Relevance for Gene Therapy Applications and Studies on Disease Pathogenesis.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S342, doi. 10.1016/j.ymthe.2006.08.977
- By:
- Publication type:
- Article
889. Adeno-Associated Virus Gene Therapy of Feline Gangliosidosis.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S342, doi. 10.1016/j.ymthe.2006.08.978
- By:
- Publication type:
- Article
890. Improvement of Behavior and Mortality Following CNS Administration of AAVrh.10hCLN2 to CLN2 −/− Mice, a Model LINCL (Battan Disease) a Fatal Childhood Neurological Disorder (Batten Disease).
- Published in:
- Molecular Therapy, 2006, v. 13, p. S343, doi. 10.1016/j.ymthe.2006.08.979
- By:
- Publication type:
- Article
891. Correction of Established Neurologic Disease and Evidences of In Vivo Cross Correction in the Mouse Model of Metachromatic Leukodystrophy.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S343, doi. 10.1016/j.ymthe.2006.08.980
- By:
- Publication type:
- Article
892. Neural Deficits Contribute to Respiratory Insufficiency in Pompe Disease: A Therapeutic Approach with AAV1.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S344, doi. 10.1016/j.ymthe.2006.08.981
- By:
- Publication type:
- Article
893. Second Generation Gene Therapy Vector for Classical Late Infantile Neuronal Ceroid Lipofuscinosis.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S344, doi. 10.1016/j.ymthe.2006.08.982
- By:
- Publication type:
- Article
894. Selective Targeting of GABAergic Neurons Using rAAV: The Potential Role of EAAC1 in Seizure Susceptibility.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S344, doi. 10.1016/j.ymthe.2006.08.983
- By:
- Publication type:
- Article
895. Separate rAAV1 Vectors Co-Infect Striatal Neurons Efficiently.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S345, doi. 10.1016/j.ymthe.2006.08.984
- By:
- Publication type:
- Article
901. Targeting of Viral Vectors to Motor Neurons by Botulinum Toxin Binding Domain To Treat ALS.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S347, doi. 10.1016/j.ymthe.2006.08.990
- By:
- Publication type:
- Article
897. Na,K-ATPase β1-Mediated Selective Gene Transfer into Neurons.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S346, doi. 10.1016/j.ymthe.2006.08.986
- By:
- Publication type:
- Article
908. Design and Optimization of U7snRNAs for Skipping of Exon 51 in DMD: Promising Tools for Future Clinical Trials.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S350, doi. 10.1016/j.ymthe.2006.08.998
- By:
- Publication type:
- Article
899. Utilizing the Vector Transport Properties of AAV-9 as a Method To Get Widespread Distribution of a Therapeutic Gene within the CNS.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S346, doi. 10.1016/j.ymthe.2006.08.988
- By:
- Publication type:
- Article
900. Specific AAV Serotypes Stably Transduce Hippocampal and Cortical Cultures with High Efficiency and Low Toxicity.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S347, doi. 10.1016/j.ymthe.2006.08.989
- By:
- Publication type:
- Article
896. Long Term Transgene Expression in the Brain Delivered by SV40-Derived Vectors.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S345, doi. 10.1016/j.ymthe.2006.08.985
- By:
- Publication type:
- Article
902. Modulation of Voltage-Gated Potassium Channels in Dorsal Root Ganglion Neurons by an Inducible Adenoviral Vector In Vivo.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S347, doi. 10.1016/j.ymthe.2006.08.991
- By:
- Publication type:
- Article
898. Intracerebral Exon Skipping Restores Dystrophin Expression in CA1 Pyramidal Neurons of mdx Mice.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S346, doi. 10.1016/j.ymthe.2006.08.987
- By:
- Publication type:
- Article
904. The Systemic Human Immune Response to Intraparenchymal Administration of AAV.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S348, doi. 10.1016/j.ymthe.2006.08.993
- By:
- Publication type:
- Article
905. The Use of Gene Immunisation To Study the Role of Antibodies to Voltage Gated Potassium Channels in Neuroimmunological Disease.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S349, doi. 10.1016/j.ymthe.2006.08.994
- By:
- Publication type:
- Article
906. Effective Repetitive Dystrophin Gene Transfer into Skeletal Muscle of Adult mdx Mice Using a Helper-Dependent Adenovirus Vector Expressing the Coxsackievirus and Adenovirus Receptor (CAR) and Dystrophin.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S349, doi. 10.1016/j.ymthe.2006.08.996
- By:
- Publication type:
- Article
907. Development of Recombinant Novel Adeno-Associated Viral (rAAV) Vectors Encoding Optimised Microdystrophin cDNAs for Duchenne Muscular Dystrophy (DMD).
- Published in:
- Molecular Therapy, 2006, v. 13, p. S349, doi. 10.1016/j.ymthe.2006.08.997
- By:
- Publication type:
- Article
903. Re-Administration of Recombinant AAV2 and AAV5 in the Brain.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S348, doi. 10.1016/j.ymthe.2006.08.992
- By:
- Publication type:
- Article